THRESHOLD PHARMACEUTICAL INC's ticker is THLD and the CUSIP is 885807206. A total of 56 filers reported holding THRESHOLD PHARMACEUTICAL INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $51,000 | – | 80,123 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 393,000 | $1,556,000 | 1.48% |
| FORTALEZA ASSET MANAGEMENT INC/ | 98,125 | $389,000 | 0.18% |
| Rhenman & Partners Asset Management AB | 121,537 | $481,000 | 0.14% |
| Baker Brothers Advisors | 1,826,358 | $7,232,000 | 0.09% |
| Rotella Capital Management, Inc. | 21,600 | $86,000 | 0.07% |
| SSI INVESTMENT MANAGEMENT LLC | 117,640 | $466,000 | 0.04% |
| FEDERATED HERMES, INC. | 2,391,400 | $9,470,000 | 0.03% |
| TFS CAPITAL LLC | 96,659 | $383,000 | 0.03% |
| SMITH ASSET MANAGEMENT GROUP LP | 191,038 | $757,000 | 0.03% |
| FRANKLIN STREET ADVISORS INC /NC | 28,000 | $111,000 | 0.02% |